AI assistant
AMICUS THERAPEUTICS, INC. — Director's Dealing 2017
Oct 16, 2017
31523_dirs_2017-10-16_3b1e741f-7b77-41c2-bfc4-dde5651c9014.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2017-10-12
Reporting Person: Crowley John F (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-10-12 | Common Stock | M | 380000 | $14.2495 | Acquired | 708001 | Direct |
| 2017-10-12 | Common Stock | S | 380000 | $14.2495 | Disposed | 328001 | Direct |
| 2017-10-13 | Common Stock | M | 22160 | $14.7503 | Acquired | 350161 | Direct |
| 2017-10-13 | Common Stock | S | 22160 | $14.7503 | Disposed | 328001 | Direct |
| 2017-10-16 | Common Stock | M | 47135 | $14.75 | Acquired | 375136 | Direct |
| 2017-10-16 | Common Stock | S | 47135 | $14.75 | Disposed | 328001 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-10-12 | Stock Options (right to buy) | $6.45 | M | 5783 | Disposed | 2022-02-15 | Common Stock (5783) | Direct |
| 2017-10-12 | Stock Options (right to buy) | $4.38 | M | 13622 | Disposed | 2022-06-04 | Common Stock (13622) | Direct |
| 2017-10-12 | Stock Options (right to buy) | $3.53 | M | 3462 | Disposed | 2023-01-28 | Common Stock (3462) | Direct |
| 2017-10-12 | Stock Options (right to buy) | $2.52 | M | 165000 | Disposed | 2023-06-18 | Common Stock (165000) | Direct |
| 2017-10-12 | Stock Options (right to buy) | $3.19 | M | 192133 | Disposed | 2024-01-03 | Common Stock (192133) | Direct |
| 2017-10-13 | Stock Options (right to buy) | $3.53 | M | 22160 | Disposed | 2023-01-28 | Common Stock (22160) | Direct |
| 2017-10-16 | Stock Options (right to buy) | $3.53 | M | 47135 | Disposed | 2023-01-28 | Common Stock (47135) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 64895 | Indirect |
Footnotes
F1: The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017.
F2: This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.09 to $14.44. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F3: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.09 to $14.44. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4: This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.75 to $14.76. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F5: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.75 to $14.76. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.